We use cookies for a better user experience. Read our Privacy Policy

I Agree

Soft Tissue Allografts Market

Soft Tissue Allografts Market (Product Type: Cartilage Allografts, Tendon Allografts, Meniscus Allografts, Collagen Allografts, and Amniotic Allografts) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Soft Tissue Allografts Market Outlook 2031

  • The global soft tissue allografts market was valued at US$ 3.74 Bn in 2021
  • The global market is projected to grow at a CAGR of 5.5% from 2022 to 2031
  • The global soft tissue allografts market is anticipated to reach more than US$ 6.3 Bn by the end of 2031

Analysts’ Viewpoint on Soft Tissue Allografts Market Scenario

Soft tissue allografts have gained popularity due to technology advancements. Aging population, increase in demand for soft tissue allografts in athletics, rise in number of tissue banks, and surge in number of orthopedic surgical procedures are driving the demand for sterile tissue allografts. Most companies are planning to launch soft tissue allografts products. Rise in awareness is projected to contribute to the growth of the global soft tissue allografts market. Patient awareness has increased significantly, in part due to growth in Internet penetration and easy access to social media. The global soft tissue allografts market is expected to benefit from increased understanding of products and procedures. Furthermore, underlying healthcare trends, growth in importance of sports, and rise in geriatric population are estimated to propel the global market.

Soft Tissue Allografts Market

Soft Tissue Allografts Market Introduction

Soft tissue allografts are used to replace deficient ligaments, torn menisci, spinal surgery, and osteochondral defects during knee surgery. Donor screening, laboratory testing, and tissue preparation are part of the three-stage safety screening process for sterile tissue allografts. Soft tissue allografts are made up of bone, tendons, cartilage, skin, heart valves, and veins; and are used in various surgeries. Soft tissue allograft has been considered a successful procedure for over 150 years, with around 1 million allografts transplanted in the U.S. each year.

Usage of soft tissue allografts has increased across the globe due to the rise in number of orthopedic surgeries and dental implants. Increase in geriatric population, rise in demand for new technological advancements for the production of new tissues by tissue banks, and surge in demand for sterile soft tissue allografts among patients are augmenting the global soft tissue allografts market. Risk of infection and immune response could lead to serious complications such as disruption of infected anastomotic rigid line with a rupture, bowel formation, and microbial infection. Furthermore, high cost of procedures with limited reimbursement is likely to restrain the global soft tissue allografts market.

Request a sample to get extensive insights into the Soft Tissue Allografts Market

Clinical Use in Medical Procedures and Sports Injuries to Drive Global Market

Modern training regimens in athletics, field events, and various other contact sports, such as American football, require athletes to participate in intensive training sessions that are often more strenuous than the sport itself. High-intensity training regimens are directly related to improved athletic performance; however, excessive training causes muscle and bone fatigue and frequently leads to injury.

Sports injury can be caused by an accident, an impact, poor training habits, lack of conditioning, improper equipment, and insufficient warm-up and stretching. Youth injuries are increasing as a result of year-round participation in a single sport. According to the American Academy of Pediatrics, around 30 million children and teenagers participate in organized sports in the U.S. each year, resulting in more than 3.5 million injuries. Sports-related injuries account for one-third of all childhood injuries.

Rise in Orthopedic and Dentistry Cases Associated with Aging to Augment Global Market

Elderly people are more likely to sustain soft tissue injuries. As people get older, they naturally slow down, have less energy, and are less powerful. Hence, they are more vulnerable to injuries. Falls is the leading cause of death among people aged over 65. It is the most common reason for elderly people to visit the emergency room.

Tooth loss is common among the geriatric population and can be caused by disease or trauma. Usage of dental implants to provide support for the replacement of missing teeth has a long and complex history. Research in dental implant designs, materials, and techniques has increased in the past few years. It is expected to rise in the near future due to the growth in the dental implants market and increase in demand for cosmetic dentistry. This is projected to drive the soft tissue allografts market size in the near future.

Increase in Number of Musculoskeletal Reconstructive Procedures Propelling Collagen Allografts Segment

In terms of product type, the collagen allografts segment dominated the global soft tissue allografts market in 2021. The trend is anticipated to continue during the forecast period. Rise in number of musculoskeletal reconstructive procedures such as anterior cruciate ligament reconstruction is likely to increase the usage of collagen allografts. Furthermore, increase in usage of collagen allografts in maxillofacial surgery and wound care therapies is expected to drive the segment during the forecast period.

Regional Analysis of Global Soft Tissue Allografts Market

North America dominated the global soft tissue allografts market in 2021. The market in the region is anticipated to grow at the fastest CAGR from 2022 to 2031 due to the presence of key players and high rate of technology adoption. Furthermore, prevalence of diabetic foot ulcers, better diabetes healthcare awareness programs, and increase in number of surgical procedures are augmenting the soft tissue allografts market share of North America.

Development of distribution channels by key players and rise in demand for collagen allografts for the treatment of severe burn injuries and breast reconstruction surgery are the factors driving the soft tissue allografts market in Asia Pacific.

Analysis of Key Players in Global Soft Tissue Allografts Market

The global soft tissue allografts market is fragmented, with the presence of large number of key players. Expansion of product portfolios and mergers & acquisitions are the major strategies adopted by the leading players. Lattice Biologics Ltd., Zimmer Biomet, AlonSource Group, MiMedix Group, AlloSource, CONMED Corporation, Organogenesis, Inc., RTI Surgical, Inc., Osiris Therapeutics, Integra LifeSciences Corporation, Globus Medical, Inc., Straumann Holding AG, Xtant Medical, Alliqua BioMedical, Inc., C. R. Bard, Inc. (Davol, Inc.), B. Braun Melsungen AG, and Arthrex are the soft tissue allografts market key players.

Request a custom report on Soft Tissue Allografts Market

Key Developments in Global Soft Tissue Allografts Market

  • In August 2022, Vivex Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatments, announced the release of CYGNUS Matrix Disks, the newest configuration of the CYGNUS family of amniotic tissue allografts. CYGNUS amniotic tissue allografts are used to cover wounds. They act as soft tissue barriers to help prevent mechanical damage. CYGNUS Matrix Disk is a flexible, multi-layer allograft that preserves the amnion layer, its intermediate/spongy layer, and the chorion layers of the amniotic sac. It also offers better handling and increased workability.
  • In August 2021, AlloSource introduced AlloMend Ultra-Thick Acellular Dermal Matrix (ADM), the newest addition to the AlloMend product line. The company is the largest allograft provider in the U.S. that develops cutting-edge cellular and tissue products to aid surgeons in healing patients. The thickest dermal graft offered by the company is AlloMend Ultra-Thick ADM, which is available in multiple sizes and has a thickness range of 3.0 mm to 4.0 mm. It is made using cutting-edge processing methods to guarantee that each allograft's thickness is constant throughout the entire graft. The product was created to be used in the replacement or repair of worn-out or insufficient tissue needed for difficult procedures such as superior capsule reconstruction (SCR).

Each of these players has been profiled in the soft tissue allografts market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments.

Global Soft Tissue Allografts Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 3.74 Bn

Market Forecast Value in 2031

More than US$ 6.3 Bn

Growth Rate (CAGR)

5.5%

Forecast Period

2022–2031

Historical Data Available for

2017–2020

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Product Type
    • Cartilage Allografts
      • Hyaline Cartilage
      • Elastic Cartilage
      • Fibro Cartilage
    • Tendon Allografts
      • Achilles Tendon
      • Tibialis
      • Patellar Tendon
      • Hamstring
    • Meniscus Allografts
    • Dental Allografts
      • Free Gingival Graft
      • Connective Tissue Graft
      • Pedicle Graft
    • Collagen Allografts
    • Amniotic Allografts
  • Application
    • Orthopedic
      • Sports Medicine
      • Spine Surgeries
      • General Orthopedic
      • Reconstruction
    • Dentistry
      • Dental Sensitivity
      • Aesthetics
    • Wound Care
    • Others
  • End-user
    • Hospitals
    • Orthopedic Clinics
    • Dental Clinics
    • Ambulatory Surgical Centers
    • Aesthetic Centers

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Russia & CIS
  • Japan
  • China
  • India
  • ASEAN
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Lattice Biologics Ltd.
  • Zimmer Biomet
  • AlonSource Group
  • MiMedix Group
  • AlloSource
  • CONMED Corporation
  • Organogenesis, Inc.
  • RTI Surgical, Inc.
  • Osiris Therapeutics
  • Integra LifeSciences Corporation
  • Globus Medical, Inc.
  • Straumann Holding AG
  • Xtant Medical
  • Alliqua BioMedical, Inc.
  • C. R. Bard, Inc. (Davol, Inc.)
  • B. Braun Melsungen AG
  • Arthrex

Customization Scope

Available upon request

Pricing

Available upon request

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

How big was the global soft tissue allografts market in 2021?

The global soft tissue allografts market was valued at US$ 3.74 Bn in 2021

How big will be the global soft tissue allografts market in 2031?

The global soft tissue allografts market is projected to reach more than US$ 6.3 Bn by 2031

What will be the CAGR of the global soft tissue allografts market during the forecast period (2022–2031)?

The global soft tissue allografts market is anticipated to grow at a CAGR of 5.5% from 2022 to 2031

What are the prominent trends that affect market growth?

Clinical use in medical procedures & sports injuries and rise in orthopedics & dentistry cases associated with aging

What is the market share of leading segment of the global soft tissue allografts market?

The collagen allografts segment held over 28% share of the global soft tissue allografts market in 2021

Which region will account for major share of the global market during the forecast period?

North America is expected to account for major share of the global soft tissue allografts makret during the forecast period.

Who are the prominent players in the global soft tissue allografts market?

Lattice Biologics Ltd., Zimmer Biomet, AlonSource Group, MiMedix Group, AlloSource, CONMED Corporation, Organogenesis, Inc., RTI Surgical, Inc., Osiris Therapeutics, Integra LifeSciences Corporation, Globus Medical, Inc., Straumann Holding AG, Xtant Medical, Alliqua BioMedical, Inc., C. R. Bard, Inc. (Davol, Inc.), B. Braun Melsungen AG, and Arthrex

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Soft Tissue Allografts Market

4. Market Overview

    4.1. Introduction

        4.1.1. Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Soft Tissue Allografts Market Analysis and Forecasts, 2017–2031

5. Key Insights

    5.1. Key Mergers & Acquisitions

    5.2. Technological Advancements

    5.3. COVID-19 Impact Analysis

6. Global Soft Tissue Allografts Market Analysis and Forecast, By Product

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product, 2017–2031

        6.3.1. Cartilage Allografts

            6.3.1.1. Hyaline Cartilage

            6.3.1.2. Elastic Cartilage

            6.3.1.3. Fibro Cartilage

        6.3.2. Tendon Allografts

            6.3.2.1. Achilles Tendon

            6.3.2.2. Tibialis

            6.3.2.3. Patellar Tendon

            6.3.2.4. Hamstring

        6.3.3. Dental Allografts

            6.3.3.1. Free Gingival Graft

            6.3.3.2. Connective Tissue Graft

            6.3.3.3. Pedicle Graft

        6.3.4. Meniscus Allografts

        6.3.5. Collagen Allografts

        6.3.6. Amniotic Allografts

    6.4. Market Attractiveness Analysis, By Product

7. Global Soft Tissue Allografts Market Analysis and Forecast, By Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Application, 2017–2031

        7.3.1. Orthopedics

            7.3.1.1. Sports Medicine

            7.3.1.2. Spine Surgeries

            7.3.1.3. General Orthopedics

            7.3.1.4. Reconstruction

        7.3.2. Dentistry

            7.3.2.1. Dental Sensitivity

            7.3.2.2. Aesthetics

        7.3.3. Wound Care

        7.3.4. Others

    7.4. Market Attractiveness Analysis, By Application

8. Global Soft Tissue Allografts Market Analysis and Forecast, By End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by End-user, 2017–2031

        8.3.1. Orthopedic Clinics

        8.3.2. Dental Clinics

        8.3.3. Ambulatory Surgical Centers

        8.3.4. Aesthetic Centers

    8.4. Market Attractiveness Analysis, By End-user

9. Global Soft Tissue Allografts Market Analysis and Forecast, By Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, By Region

10. North America Soft Tissue Allografts Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product, 2017–2031

        10.2.1. Cartilage Allografts

            10.2.1.1. Hyaline Cartilage

            10.2.1.2. Elastic Cartilage

            10.2.1.3. Fibro Cartilage

        10.2.2. Tendon Allografts

            10.2.2.1. Achilles Tendon

            10.2.2.2. Tibialis

            10.2.2.3. Patellar Tendon

            10.2.2.4. Hamstring

        10.2.3. Dental Allografts

            10.2.3.1. Free Gingival Graft

            10.2.3.2. Connective Tissue Graft

            10.2.3.3. Pedicle Graft

        10.2.4. Meniscus Allografts

        10.2.5. Collagen Allografts

        10.2.6. Amniotic Allografts

    10.3. Market Value Forecast, by Application, 2017–2031

        10.3.1. Orthopedics

            10.3.1.1. Sports Medicine

            10.3.1.2. Spine Surgeries

            10.3.1.3. General Orthopedics

            10.3.1.4. Reconstruction

        10.3.2. Dentistry

            10.3.2.1. Dental Sensitivity

            10.3.2.2. Aesthetics

        10.3.3. Wound Care

        10.3.4. Others

    10.4. Market Value Forecast, by End-user, 2017–2031

        10.4.1. Orthopedic Clinics

        10.4.2. Dental Clinics

        10.4.3. Ambulatory Surgical Centers

        10.4.4. Aesthetic Centers

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Product

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Soft Tissue Allografts Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product, 2017–2031

        11.2.1. Cartilage Allografts

            11.2.1.1. Hyaline Cartilage

            11.2.1.2. Elastic Cartilage

            11.2.1.3. Fibro Cartilage

        11.2.2. Tendon Allografts

            11.2.2.1. Achilles Tendon

            11.2.2.2. Tibialis

            11.2.2.3. Patellar Tendon

            11.2.2.4. Hamstring

        11.2.3. Dental Allografts

            11.2.3.1. Free Gingival Graft

            11.2.3.2. Connective Tissue Graft

            11.2.3.3. Pedicle Graft

        11.2.4. Meniscus Allografts

        11.2.5. Collagen Allografts

        11.2.6. Amniotic Allografts

    11.3. Market Value Forecast, by Application, 2017–2031

        11.3.1. Orthopedics

            11.3.1.1. Sports Medicine

            11.3.1.2. Spine Surgeries

            11.3.1.3. General Orthopedics

            11.3.1.4. Reconstruction

        11.3.2. Dentistry

            11.3.2.1. Dental Sensitivity

            11.3.2.2. Aesthetics

        11.3.3. Wound Care

        11.3.4. Others

    11.4. Market Value Forecast, by End-user, 2017–2031

        11.4.1. Orthopedic Clinics

        11.4.2. Dental Clinics

        11.4.3. Ambulatory Surgical Centers

        11.4.4. Aesthetic Centers

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Italy

        11.5.5. Spain

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Product

        11.6.2. By Application

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Soft Tissue Allografts Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product, 2017–2031

        12.2.1. Cartilage Allografts

            12.2.1.1. Hyaline Cartilage

            12.2.1.2. Elastic Cartilage

            12.2.1.3. Fibro Cartilage

        12.2.2. Tendon Allografts

            12.2.2.1. Achilles Tendon

            12.2.2.2. Tibialis

            12.2.2.3. Patellar Tendon

            12.2.2.4. Hamstring

        12.2.3. Dental Allografts

            12.2.3.1. Free Gingival Graft

            12.2.3.2. Connective Tissue Graft

            12.2.3.3. Pedicle Graft

        12.2.4. Meniscus Allografts

        12.2.5. Collagen Allografts

        12.2.6. Amniotic Allografts

    12.3. Market Value Forecast, by Application, 2017–2031

        12.3.1. Orthopedics

            12.3.1.1. Sports Medicine

            12.3.1.2. Spine Surgeries

            12.3.1.3. General Orthopedics

            12.3.1.4. Reconstruction

        12.3.2. Dentistry

            12.3.2.1. Dental Sensitivity

            12.3.2.2. Aesthetics

        12.3.3. Wound Care

        12.3.4. Others

    12.4. Market Value Forecast, by End-user, 2017–2031

        12.4.1. Orthopedic Clinics

        12.4.2. Dental Clinics

        12.4.3. Ambulatory Surgical Centers

        12.4.4. Aesthetic Centers

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Product

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Soft Tissue Allografts Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product, 2017–2031

        13.2.1. Cartilage Allografts

            13.2.1.1. Hyaline Cartilage

            13.2.1.2. Elastic Cartilage

            13.2.1.3. Fibro Cartilage

        13.2.2. Tendon Allografts

            13.2.2.1. Achilles Tendon

            13.2.2.2. Tibialis

            13.2.2.3. Patellar Tendon

            13.2.2.4. Hamstring

        13.2.3. Dental Allografts

            13.2.3.1. Free Gingival Graft

            13.2.3.2. Connective Tissue Graft

            13.2.3.3. Pedicle Graft

        13.2.4. Meniscus Allografts

        13.2.5. Collagen Allografts

        13.2.6. Amniotic Allografts

    13.3. Market Value Forecast, by Application, 2017–2031

        13.3.1. Orthopedics

            13.3.1.1. Sports Medicine

            13.3.1.2. Spine Surgeries

            13.3.1.3. General Orthopedics

            13.3.1.4. Reconstruction

        13.3.2. Dentistry

            13.3.2.1. Dental Sensitivity

            13.3.2.2. Aesthetics

        13.3.3. Wound Care

        13.3.4. Others

    13.4. Market Value Forecast, by End-user, 2017–2031

        13.4.1. Orthopedic Clinics

        13.4.2. Dental Clinics

        13.4.3. Ambulatory Surgical Centers

        13.4.4. Aesthetic Centers

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Product

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Soft Tissue Allografts Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product, 2017–2031

        14.2.1. Cartilage Allografts

            14.2.1.1. Hyaline Cartilage

            14.2.1.2. Elastic Cartilage

            14.2.1.3. Fibro Cartilage

        14.2.2. Tendon Allografts

            14.2.2.1. Achilles Tendon

            14.2.2.2. Tibialis

            14.2.2.3. Patellar Tendon

            14.2.2.4. Hamstring

        14.2.3. Dental Allografts

            14.2.3.1. Free Gingival Graft

            14.2.3.2. Connective Tissue Graft

            14.2.3.3. Pedicle Graft

        14.2.4. Meniscus Allografts

        14.2.5. Collagen Allografts

        14.2.6. Amniotic Allografts

    14.3. Market Value Forecast, by Application, 2017–2031

        14.3.1. Orthopedics

            14.3.1.1. Sports Medicine

            14.3.1.2. Spine Surgeries

            14.3.1.3. General Orthopedic

            14.3.1.4. Reconstruction

        14.3.2. Dentistry

            14.3.2.1. Dental Sensitivity

            14.3.2.2. Aesthetics

        14.3.3. Wound Care

        14.3.4. Others

    14.4. Market Value Forecast, by End-user, 2017–2031

        14.4.1. Orthopedic Clinics

        14.4.2. Dental Clinics

        14.4.3. Ambulatory Surgical Centers

        14.4.4. Aesthetic Centers

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Product

        14.6.2. By Application

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Market Share Analysis, by Company, 2021

    15.3. Company Profiles

        15.3.1. Lattice Biologics Ltd

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Product Portfolio

            15.3.1.3. SWOT Analysis

            15.3.1.4. Strategic Overview

        15.3.2. Zimmer Biomet

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Product Portfolio

            15.3.2.3. SWOT Analysis

            15.3.2.4. Strategic Overview

        15.3.3. AlonSource Group

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Product Portfolio

            15.3.3.3. SWOT Analysis

            15.3.3.4. Strategic Overview

        15.3.4. MiMedix Group.

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Product Portfolio

            15.3.4.3. SWOT Analysis

            15.3.4.4. Strategic Overview

        15.3.5. AlloSource.

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Product Portfolio

            15.3.5.3. SWOT Analysis

            15.3.5.4. Strategic Overview

        15.3.6. CONMED Corporation.

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Product Portfolio

            15.3.6.3. SWOT Analysis

            15.3.6.4. Strategic Overview

        15.3.7. Organogenesis, Inc.

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Product Portfolio

            15.3.7.3. SWOT Analysis

            15.3.7.4. Strategic Overview

        15.3.8. RTI Surgical, Inc.

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Product Portfolio

            15.3.8.3. SWOT Analysis

            15.3.8.4. Strategic Overview

        15.3.9. Osiris Therapeutics.

            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Product Portfolio

            15.3.9.3. SWOT Analysis

            15.3.9.4. Strategic Overview

        15.3.10. Integra LifeSciences Corporation.

            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.10.2. Product Portfolio

            15.3.10.3. SWOT Analysis

            15.3.10.4. Strategic Overview

        15.3.11. Globus Medical, Inc.

            15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.11.2. Product Portfolio

            15.3.11.3. SWOT Analysis

            15.3.11.4. Strategic Overview

        15.3.12. B. Braun Melsungen AG.

            15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.12.2. Product Portfolio

            15.3.12.3. SWOT Analysis

            15.3.12.4. Strategic Overview

        15.3.13. Arthrex

            15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.13.2. Product Portfolio

            15.3.13.3. SWOT Analysis

            15.3.13.4. Strategic Overview

List of Tables

Table 01: Global Soft Tissue Allografts Market Pipeline Analysis

Table 02: Global Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Product Type, 2022–2031

Table 03: Global Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Application, 2022–2031

Table 04: Global Soft Tissue Allografts Market (US$ Mn) Forecast, by Region, 2022–2031

Table 05: North America Soft Tissue Allografts Market (US$ Mn) Forecast, by Country, 2022–2031

Table 06: North America Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Product Type, 2022–2031

Table 07: North America Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Application, 2022–2031

Table 08: North America Soft Tissue Allografts Market Size (US$ Mn) Forecast, by End-user, 2022–2031

Table 09: Europe Soft Tissue Allografts Market (US$ Mn) Forecast, by Country/Sub-region, 2022–2031

Table 10: Europe Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Product Type, 2022–2031

Table 11: Europe Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Application, 2022–2031

Table 12: Europe Soft Tissue Allografts Market Size (US$ Mn) Forecast, by End-user,2022–2031

Table 13: Asia Pacific Soft Tissue Allografts Market (US$ Mn) Forecast, by Country/Sub-region, 2022–2031

Table 14: Asia Pacific Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Product Type, 2022–2031

Table 15: Asia Pacific Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Application, 2022–2031

Table 16: Asia Pacific Soft Tissue Allografts Market Size (US$ Mn) Forecast, by End-user, 2022–2031

Table 17: Latin America Soft Tissue Allografts Market (US$ Mn) Forecast, by Country/Sub-region, 2022–2031

Table 18: Latin America Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Product Type, 2022–2031

Table 19: Latin America Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Application, 2022–2031

Table 20: Latin America Soft Tissue Allografts Market (US$ Mn) Forecast, by End-user, 2022–2031

Table 21: Middle East & Africa Soft Tissue Allografts Market (US$ Mn) Forecast, by Country/Sub-region, 2022–2031

Table 22: Middle East & Africa Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Product Type, 2022–2031

Table 23: Middle East & Africa Soft Tissue Allografts Market Size (US$ Mn) Forecast, by Application, 2022–2031

Table 24: Middle East & Africa Soft Tissue Allografts Market (US$ Mn) Forecast, by End-user, 2022–2031

List of Figures

Figure 01: Global Soft Tissue Allografts Market (US$ Mn) Forecast, 2017–2031

Figure 02: Global Soft Tissue Allografts Market Share Analysis, by Product Type, 2021 and 2031

Figure 03: Global Soft Tissue Allografts Market Share Analysis, by Application, 2021 and 2031

Figure 04: Global Soft Tissue Allografts Market Share Analysis, by End-user, 2021 and 2031

Figure 05: Global Soft Tissue Allografts Market (US$ Mn) Forecast, by Product Type, 2017–2031

Figure 06: Global Soft Tissue Allografts Market (US$ Mn) Forecast, by Application, 2017–2031

Figure 07: Global Soft Tissue Allografts Market (US$ Mn) Forecast, by End-user, 2017–2031

Figure 08: North America Soft Tissue Allografts Market (US$ Mn) Forecast, 2017–2031

Figure 09: North America Soft Tissue Allografts Market Share Analysis, by Country, 2021 and 2031

Figure 10: North America Soft Tissue Allografts Market Attractiveness Analysis, by Country, 2022–2031

Figure 11: North America Soft Tissue Allografts Market Share Analysis, by Product type, 2021 and 2031

Figure 12: North America Soft Tissue Allografts Market Share Analysis, by Application, 2021 and 2031

Figure 13: North America Soft Tissue Allografts Market Share Analysis, by End-user, 2021 and 2031

Figure 14: North America Soft Tissue Allografts Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 15: North America Soft Tissue Allografts Market Attractiveness Analysis, by Application, 2022–2031

Figure 16: North America Soft Tissue Allografts Market Attractiveness Analysis, by End-user, 2022–2031

Figure 17: Europe Soft Tissue Allografts Market(US$ Mn) Forecast, 2017–2031

Figure 18: Europe Soft Tissue Allografts Market Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 19: Europe Soft Tissue Allografts Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 20: Europe Soft Tissue Allografts Market Share Analysis, by Product type, 2021 and 2031

Figure 21: Europe Soft Tissue Allografts Market Share Analysis, by Application, 2021 and 2031

Figure 22: Europe Soft Tissue Allografts Market Share Analysis, by End-user, 2021 and 2031

Figure 23: Europe Soft Tissue Allografts Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 24: Europe Soft Tissue Allografts Market Attractiveness Analysis, by Application, 2022–2031

Figure 25: Europe Soft Tissue Allografts Market Attractiveness Analysis, by End-user, 2022–2031

Figure 26: Asia Pacific Soft Tissue Allografts Market(US$ Mn) Forecast, 2017–2031

Figure 27: Asia Pacific Soft Tissue Allografts Market Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 28: Asia Pacific Soft Tissue Allografts Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 29: Asia Pacific Soft Tissue Allografts Market Share Analysis, by Product Type, 2021 and 2031

Figure 30: Asia Pacific Soft Tissue Allografts Market Share Analysis, by Application, 2021 and 2031

Figure 31: Asia Pacific Soft Tissue Allografts Market Share Analysis, by End-user, 2021 and 2031

Figure 32: Asia Pacific Soft Tissue Allografts Market Attractiveness Analysis, by Application, 2022–2031

Figure 33: Asia Pacific Soft Tissue Allografts Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 34: Asia Pacific Soft Tissue Allografts Market Attractiveness Analysis, by End-user, 2022–2031

Figure 35: Latin America Soft Tissue Allografts Market(US$ Mn) Forecast, 2017–2031

Figure 36: Latin America Soft Tissue Allografts Market Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 37: Latin America Soft Tissue Allografts Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 38: Latin America Soft Tissue Allografts Market Share Analysis, by Product Type, 2021 and 2031

Figure 39: Latin America Soft Tissue Allografts Market Share Analysis, by Application, 2021 and 2031

Figure 40: Latin America Soft Tissue Allografts Market Share Analysis, by End-user, 2021 and 2031

Figure 41: Latin America Tissue Allografts Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 42: Latin America Tissue Allografts Market Attractiveness Analysis, by Application, 2022–2031

Figure 43: Latin America Soft Tissue Allografts Market Attractiveness Analysis, by End-user, 2022–2031

Figure 44: Middle East & Africa Soft Tissue Allografts Market(US$ Mn) Forecast, 2017–2031

Figure 45: Middle East & Africa Soft Tissue Allografts Market Share Analysis, by Country/Sub-region, 2021 and 2031

Figure 46: Middle East & Africa Soft Tissue Allografts Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 46: Middle East & Africa Soft Tissue Allografts Market Share Analysis, by Product Type, 2021 and 2031

Figure 47: Middle East & Africa Soft Tissue Allografts Market Share Analysis, by Application, 2021 and 2031

Figure 48: Middle East & Africa Soft Tissue Allografts Market Share Analysis, by End-user, 2021 and 2031

Figure 49: Middle East & Africa Tissue Allografts Market Attractiveness Analysis, by Product Type, 2022–2031

Figure 50: Middle East & Africa Tissue Allografts Market Attractiveness Analysis, by Application, 2022–2031

Figure 51: Middle East & Africa Tissue Allografts Market Attractiveness Analysis, by End-user, 2022–2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

554

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved